Free tool
Stocks near their 52-week high
We cover 18 companies trading within 5% of their own 52-week high. The median market value in the group is $5.46B. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from +18.2% to +151.8% across the middle 80 percent of the group, with a median of +49.3%.
Other lists in this group
Table
18 of 3,992 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% | Oct 27, 2026 |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% | Oct 27, 2026 |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% | Oct 27, 2026 |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% | Oct 27, 2026 |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% | Oct 26, 2026 |
| CHE | Chemed Corporation | $7.11B | Mid cap | +20.79% | Oct 27, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| RCUS | Arcus Biosciences, Inc. | $3.92B | Mid cap | +191.29% | Oct 27, 2026 |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% | Oct 23, 2026 |
| ATRC | AtriCure, Inc. | $2.45B | Mid cap | +29.14% | Oct 27, 2026 |
| NEO | NeoGenomics, Inc. | $2.26B | Mid cap | +145.34% | Oct 27, 2026 |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% | Oct 22, 2026 |
| ANGO | AngioDynamics, Inc. | $648.51M | Small cap | +56.74% | Oct 1, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% | Aug 28, 2026 |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% | Sep 29, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.